| RS2483563364 |
SERAC1
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS2483565897 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome due to tenascin-X deficiency, Vesicoureteral reflux 8 |
| RS2483587351 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483588824 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 3, Joubert syndrome 3 |
| RS2483588910 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483589449 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2483590050 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483591737 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483596451 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2483598094 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483598377 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2483604684 |
TNXB
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2483669672 |
CDK13
|
Health Risk |
Pathogenic |
— |
| RS2483670958 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
CDK13-related disorder, CDK13-related disorder |
| RS2483675511 |
CDK13
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2483675974 |
CDK13
|
Health Risk |
Pathogenic |
— |
| RS2483692133 |
SFRP4
|
Health Risk |
Likely pathogenic |
— |
| RS2483700484 |
PDE10A
|
Health Risk |
Likely pathogenic |
Infantile-onset generalized dyskinesia with orofacial involvement, Infantile-onset generalized dyskinesia with orofacial involvement |
| RS2483701960 |
TNXB
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2483708247 |
AXIN2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2483753979 |
CDK13
|
Health Risk |
Likely pathogenic |
CDK13-related disorder, CDK13-related disorder |
| RS2483771537 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2483771746 |
CDK13
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2483772174 |
TNXB
|
Health Risk |
Likely pathogenic |
Vesicoureteral reflux 8, Vesicoureteral reflux 8 |
| RS2483776146 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2483783437 |
CDK13
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2483876525 |
PKD1L1
|
Health Risk |
Pathogenic |
— |
| RS2483878852 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2483878861 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2483884719 |
PKD1L1
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS2483930312 |
GRM1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 13, Autosomal recessive spinocerebellar ataxia 13 |
| RS2483940673 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2483942654 |
PKD1L1
|
Health Risk |
Likely pathogenic |
Heterotaxy, visceral |
| RS2483963312 |
PRKN
|
Health Risk |
Pathogenic |
— |
| RS2483987048 |
CDK13
|
Health Risk |
Pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2484001104 |
GRM1
|
Health Risk |
Pathogenic |
Cerebellar ataxia, Cerebellar ataxia |
| RS2484006186 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2484009005 |
PKD1L1
|
Health Risk |
Likely pathogenic |
— |
| RS2484009393 |
PKD1L1
|
Health Risk |
Likely pathogenic |
— |
| RS2484020419 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484021103 |
HACE1
|
Health Risk |
Pathogenic |
Spastic paraplegia-severe developmental delay-epilepsy syndrome, Spastic paraplegia-severe developmental delay-epilepsy syndrome |
| RS2484023860 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2484024185 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2484026671 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484029614 |
CDK13
|
Health Risk |
Pathogenic |
— |
| RS2484034993 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS2484035743 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2484036120 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2484056741 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2484059424 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2484066893 |
CDK13
|
Health Risk |
Likely pathogenic |
— |
| RS2484097162 |
PKD1L1
|
Health Risk |
Likely pathogenic |
PKD1L1-related disorder, PKD1L1-related disorder |
| RS2484101705 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2484119129 |
SAR1B
|
Health Risk |
Likely pathogenic |
Chylomicron retention disease, Chylomicron retention disease |
| RS2484133876 |
MPLKIP
|
Health Risk |
Likely pathogenic |
Trichothiodystrophy 4, nonphotosensitive |
| RS2484134094 |
MPLKIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichothiodystrophy 4, nonphotosensitive |
| RS2484141220 |
MPLKIP
|
Health Risk |
Pathogenic |
— |
| RS2484142427 |
MPLKIP
|
Health Risk |
Pathogenic |
— |
| RS2484143490 |
SAR1B
|
Health Risk |
Pathogenic |
— |
| RS2484163618 |
GRM1
|
Health Risk |
Likely pathogenic |
— |
| RS2484177690 |
GRIK2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with impaired language and ataxia and with or without seizures, Neurodevelopmental disorder with impaired language and ataxia and with or without seizures |
| RS2484185240 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484185872 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484186373 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2484189983 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484190981 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2484191788 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484202485 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2484204512 |
DNAAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
DNAAF5-related disorder, Primary ciliary dyskinesia 18 |
| RS2484210332 |
PGAM2
|
Health Risk |
Pathogenic |
Glycogen storage disease type X, Glycogen storage disease type X |
| RS2484210663 |
PGAM2
|
Health Risk |
Pathogenic |
Glycogen storage disease type X, Glycogen storage disease type X |
| RS2484210705 |
PGAM2
|
Health Risk |
Pathogenic |
Glycogen storage disease type X, Glycogen storage disease type X |
| RS2484266469 |
AK9
|
Health Risk |
Pathogenic |
Spermatogenic failure 89, Spermatogenic failure 89 |
| RS2484269420 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2484272408 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2484304425 |
RARS2
|
Health Risk |
Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontocerebellar hypoplasia type 6 |
| RS2484305794 |
RARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 6, Pontoneocerebellar hypoplasia |
| RS2484306377 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2484309410 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS2484309526 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2484309736 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS2484324739 |
PLG
|
Health Risk |
Likely pathogenic |
— |
| RS2484341342 |
AEBP1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS2484351488 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS2484355096 |
AEBP1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS2484356584 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS2484356955 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS2484357529 |
AEBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2484359175 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS2484360667 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS2484361638 |
GLI3
|
Health Risk |
Likely pathogenic |
GLI3-related disorder, GLI3-related disorder |
| RS2484361735 |
AEBP1
|
Health Risk |
Pathogenic |
— |
| RS2484363262 |
GLI3
|
Health Risk |
Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484364138 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2484364434 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484364568 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484365220 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484366559 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS2484367143 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS2484367171 |
GLI3
|
Health Risk |
Pathogenic/Likely pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |